Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Spotlight on the top 10 pharma employers of 2023

By Brian Buntz | April 26, 2023

Top 10 employers in pharmaThis roundup explores the top 10 pharma employers of 2023, highlighting their strengths and areas for improvement based on employee reviews and industry trends. In our ranking of top  employers, we combined data from multiple sources using a weighted approach, emphasizing employee satisfaction, company benefits and industry recognition. Topping the list are Recursion Pharmaceuticals and Ultragenyx. Both won employee support for their strong culture, supportive leadership and commitment to employee well-being.

Criteria for ranking the top 10 pharma employers of 2023

Before diving into the top 10 pharma employers of 2023, it’s important to note the factors contributing to their success. We considered multiple metrics in this listing. To rank the companies, we used a weighted approach, assigning 0.7 weight to Glassdoor ratings and 0.3 weight to Comparably ratings. On top of that, we evaluated the company’s benefits, giving 0.1 weight to this metric. Additionally, we added bonus points (0.5 each) for inclusion in top employer rankings from Indeed, Fortune and Forbes.

[Check out our companion article, which provides the scores for the top 25 pharma employers of 2023 and our coverage ofthe best pharma companies to work for in 2022.]

Top pharma employers of 2023

1. Recursion Pharmaceuticals: Strong culture and mission make the firm the top 10 pharma employer of 2023

Pros: The biotech company has a strong culture, mission and vision, according to Glassdoor reviewers. Employees find the leadership supportive. A total of 91% support CEO Chistopher C. Gibson. Most workers find the workplace atmosphere to be positive, with opportunities for advancement for junior employees. Glassdoor reviewers also praise the company’s generous salary, health benefits and interdisciplinary approach to drug discovery.

Cons: In the negative column, some employees report concerns with middle management and express concerns about the fast pace and technical debt.

2. Ultragenyx Pharmaceutical: Passionate teams, work-life balance and patient-centric focus

Pros: Glassdoor reviewers appreciate Ultragenyx’s passionate teams, great work/life balance, diverse culture and the company’s focus on rare genetic diseases. A total of 90% support CEO Emil Kakkis. The majority of reviewers praise the company’s results-oriented culture commitment to teamwork. Employees also value the company’s benefits and emphasis on patient centricity.

Cons: Some workers have concerns about upper management, communication and inexperienced managers.

3. Merck: Competitive pay and benefits, but some find management challenges

Pros: Merck offers competitive benefits and pay compared to other pharma companies, according to Glassdoor reviewers. Employees appreciate the year-end bonus and work/life balance. Merck CEO Robert Davis is popular, winning the support of 91% of Glassdoor reviewers.
Cons: Some workers have concerns about management, citing a lack of trust between management and representatives, frequent layoffs and reorganizations. On Comparably, the company’s overall culture has an A- ranking.

4. Novartis: Good work-life balance, talented colleagues but management issues

Pros: Glassdoor reviewers highlight the company’s work-life balance, attractive benefits, talented colleagues and culture. The company also has a strong investment in R&D. CEO Vas Narasimhan is popular. On Comparably, he has the support of 85% of Novartis employees and the support of 83% on Glassdoor. The company’s culture is also strong, winning a score of 4.6 out of 6 on Comparably. Four out of five people leaving Glassdoor reviews would recommend the firm to a friend.

Cons: Some employees report poor management, citing concerns about leadership and bureaucracy. Other workers note limited growth opportunities depending on the team.

5. Eli Lilly: Great benefits, supportive environment but complaints of bureaucracy

Pros: Employees at the Big Pharma firm, which was founded in 1876, value its great benefits and the company’s commitment to employee well-being, according to Glassdoor reviewers. The company strives to maintain a good work/life balance and is patient-centered. Most workers are happy with their pay and workplace conditions. A total of 77% of Glassdoor reviewers would recommend the company to a friend. A total of 84% workers support David A. Ricks on Glassdoor.

Cons: Some reviewers have expressed concerns about talent identification for promotions, bureaucratic and political concerns. Others complain of frequent layoffs and restructures.

6. AstraZeneca: Diverse pipeline, work-life balance but management concerns

Pros: Glassdoor reviewers appreciate AstraZeneca’s benefits, work-life balance, inclusivity, pay and culture. Many workers are upbeat about its global pipeline. The company’s CEO Pascal Soriot is popular, winning the support of 94% of 2,754 Glassdoor reviewers. A total of 85% would recommend the firm to a friend.
Cons: Some workers note concerns about direct-line management, complaining of executives focusing on their own advancement. Other complaints include frequent layoffs and limited growth opportunities.

7. GSK: Good benefits, work-life balance, but leadership diversity questions

Pros: GSK offers competitive benefits, an attractive share scheme and outstanding pay, according to Glassdoor reviews. Employees enjoy the work-life balance and the opportunity to work with great people. Most workers like the company’s culture, and employees praise the opportunity to work on a variety of project types. CEO Emma Walmsley is popular, winning the backing of 84% of 3,119 Glassdoor reviewers.

Cons: Some workers have concerns about poor management, difficulty staying motivated with poor management. One theme in negative Glassdoor reviews involved a perceived lack of diversity in senior leadership.

8. AbbVie: Growing company, supportive culture, but leadership challenges

Pros: Glassdoor reviewers praise AbbVie for its good benefits, helpful team of employees, great culture, good work-life balance, and competitive pay for contractors. A total of 86% support CEO Richard A. Gonzalez, and the majority of employees appreciate the company’s growth and opportunities.

Cons: Some workers have concerns about the lack of supportive leaders and HR issues. Additionally, some employees feel that the work-life balance can be challenging despite senior leadership’s efforts to improve in this area.

9. Pfizer: Strong purpose and culture with management and reorganization concerns

Pros: Glassdoor reviewers appreciate Pfizer’s good benefits, workplace culture, and work-life balance. Employees value the company’s purpose and culture, as well as the competitive pay. Additionally, a total of 87% of reviewers on Glassdoor support CEO Albert Bourla, while four out of five workers would recommend the company to a friend.

Cons: Some workers have concerns about poor management, constant reorganizations and layoffs, micro-managing, and long hours. Some employees also believe that middle and upper management are out of touch.

10. Horizon Therapeutics: Unique benefits, positive culture but remote work complaints

Pros: Horizon Therapeutics is praised by Glassdoor reviewers for its unique benefits, positive work culture, and emphasis on employee well-being. A total of 90% support CEO Timothy P. Walbert. Employees appreciate the company’s commitment to work-life balance and opportunities for growth. A total of 88% of Glassdoor reviewers would recommend Horizon to friends.

Cons: Some workers have concerns about the company’s approach to remote work and communication challenges. The company’s leadership “hasn’t recognized that hybrid and remote work are here to stay,” according to several reviewers.


Filed Under: Cell & gene therapy, Drug Discovery, Drug Discovery and Development, Pharma 50, Special Feature
Tagged With: best workplaces, employee satisfaction, industry recognition, pharma employers, top companies
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

The 2025 Drug Discovery & Development Pharma 50 Report: Deep Dives
Sanofi in the Drug Discovery & Development Pharma 50
Sanofi opens $130M corporate hub in New Jersey as part of $20B U.S. investment push
Pharma 50 Deep Dive: Oncology leads with $110B in sales; GLP-1s continue surge
Top 25 investors in pharma R&D in 2024
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE